1. AstraZeneca pays Sobi $95M for priority review voucher — Amgen, Allergan biosimilar of Roche's blockbuster Rituxan clears another US pivotal study — Retrophin sinks as drug “Pharma Bro” Martin Shkreli co-invented fails — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

NuVasive

Anonymous board for NuVasive

Sort By:
Title
Replies Views
Last Message ↓
  1. Anonymous
    Replies:
    1
    Views:
    2,398
  2. Anonymous
    Replies:
    6
    Views:
    3,999
  3. Anonymous
    Replies:
    41
    Views:
    20,604
  4. Anonymous
    Replies:
    13
    Views:
    5,051
  5. Anonymous
    Replies:
    1
    Views:
    3,033
  6. Anonymous
    Replies:
    5
    Views:
    2,578
  7. Anonymous
    Replies:
    3
    Views:
    2,230
  8. Anonymous
    Replies:
    0
    Views:
    2,802
  9. Anonymous
    Replies:
    0
    Views:
    1,293
  10. Anonymous
    Replies:
    2
    Views:
    2,271
  11. Anonymous
    Replies:
    0
    Views:
    1,685
  12. Anonymous
    Replies:
    1
    Views:
    2,091
  13. Anonymous
    Replies:
    3
    Views:
    1,727
  14. Anonymous
    Replies:
    0
    Views:
    1,545
  15. Anonymous
    Replies:
    13
    Views:
    2,640
  16. Anonymous
    Replies:
    12
    Views:
    4,406
  17. Anonymous
    Replies:
    11
    Views:
    2,067
  18. Anonymous
    Replies:
    45
    Views:
    28,255
  19. Anonymous
    Replies:
    8
    Views:
    3,246
  20. Anonymous
    Replies:
    0
    Views:
    1,415

Thread Display Options

Loading...